ScholarIQanswers from OpenAlex

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

PaperCitations, authors & open-access status

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients have?

ScholarIQcitation count

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients has 1,286 citations in the OpenAlex counts ScholarIQ stores.

When was Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients published?

ScholarIQyear

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients has 2021 year in the ScholarIQ index.

What is the open-access status of Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients?

ScholarIQoa status

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients has bronze oa status in the ScholarIQ index.

What is the DOI of Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients?

ScholarIQdoi

The DOI for Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients is on the source record.

What is the PMID of Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients?

ScholarIQpmid

The PMID for Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients is on the source record.

What is the OpenAlex record for Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients?

ScholarIQopenalex

The OpenAlex for Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial